Viemed Healthcare Reports Q2 2026 Financial Results

What Happened

• On August 3, 2026, Viemed Healthcare, Inc. (VMD) announced its financial results for the three and six months ended June 30, 2026 via a press release and an accompanying Financial Supplement.
• The press release is attached as Exhibit 99.1 and the Financial Supplement as Exhibit 99.2 to the Form 8-K; the filing also includes the Inline XBRL cover page (Exhibit 104).
• Per General Instruction B.2 of Form 8-K, these materials are furnished (not “filed”) and therefore are not subject to Section 18 liability or automatically incorporated by reference into other filings.

Key Details

• Event date: August 3, 2026 (press release and Financial Supplement issued).
• Reporting periods: results presented for the three-month and six-month periods ended June 30, 2026.
• Exhibits included: Press Release (Exhibit 99.1), Financial Supplement (Exhibit 99.2), and Inline XBRL cover page (Exhibit 104).
• Legal note: Information is furnished under Item 2.02 (Results of Operations and Financial Condition) and is not deemed filed under the Exchange Act per General Instruction B.2.

Why It Matters

• This 8-K provides investors with Viemed’s latest quarterly and year-to-date financial performance (Q2 2026 and six months ended June 30, 2026), which is necessary to assess recent revenue, earnings trends, and operational results.
• Because the materials are furnished rather than filed, they inform investors but have different legal treatment (not subject to Section 18 liability and not automatically incorporated by reference into future securities filings).
• Investors should review the attached press release and Financial Supplement for the specific financial figures and comparisons to prior periods or guidance.